Upper Limb Training Modalities in Patients With Stroke
Launched by UNIVERSITA DI VERONA · Jul 17, 2018
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
This single-blind RCT with two parallel group was conducted according to the tenets of the Declaration of Helsinki, the guidelines for Good Clinical practice, and the Consolidated Standards of Reporting Trials (CONSORT).
Target population was chronic post-stroke patients who attend to the Neurorehabilitation Unit (AOUI Verona) where they were assessed for eligibility.
Who satisfied inclusion and exclusion criteria were randomly allocated in one of two groups, experimental group ad control group. Each patient, underwent BoNT injection in the paretic limb. The dose of BoNT injected into the...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age \> 18 years;
- • diagnosis of ischemic or hemorrhagic first-ever stroke as documented by a computerized tomography scan or magnetic resonance imaging;
- • at least 6 months since stroke;
- • Modified Ashworth Scale (MAS) score (shoulder and elbow) ≤ 3 and ≥1+;
- • BoNT injection within the previous 12 weeks of at least one of muscles of the affected upper limb;
- • Mini-Mental State Examination (MMSE) score ≥24
- • Trunk Control Test score = 100/100.
- Exclusion Criteria:
- • any type of rehabilitation intervention in the 3 months prior to recruitment;
- • bilateral cerebrovascular lesion;
- • severe neuropsychologic impairment (global aphasia, severe attention deficit or neglect);
- • concomitant orthopedic disorders.
Trial Officials
Nicola Smania, Professor
Principal Investigator
Universita di Verona
About Universita Di Verona
The Università di Verona is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university collaborates with various healthcare professionals and institutions to explore new therapies and improve patient outcomes. Its research initiatives are driven by a multidisciplinary approach, leveraging cutting-edge technology and methodologies. The Università di Verona aims to contribute significantly to the scientific community and public health by fostering rigorous clinical studies that address pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Verona, Italy, Verona, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials